High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.

Pierotti, A R

High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome. [electronic resource] - Neuroscience letters Jan 1986 - 141-6 p. digital

Publication Type: Comparative Study; Journal Article

0304-3940

10.1016/0304-3940(86)90051-0 doi


Age Factors
Aged
Alzheimer Disease--metabolism
Choline O-Acetyltransferase--metabolism
Down Syndrome--metabolism
Female
Humans
Male
Middle Aged
Molecular Weight
Peptides--analysis
Somatostatin--analysis
Somatostatin-28
Temporal Lobe--analysis